Press Releases Bausch + Lomb Corporation

Equities

BLCO

CA0717051076

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
14.79 ^USD	+0.20%		+1.02%	-13.31%

Apr. 25	Bausch + Lomb Says Study Shows Improvements in Dry Eyes With Nutritional Supplement	MT
Apr. 25	Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes	Apr. 25	BU
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs	Apr. 18	BU
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1	Apr. 15	BU
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan	Apr. 12	AQ
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029	Apr. 12	AQ
Bausch Health to Announce First-Quarter 2024 Results on May 2	Apr. 12	AQ
Bausch Health - Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations	Apr. 03	AQ
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting	Mar. 27	BU
Bausch Health - New Survey Finds More than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information about Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure	Mar. 06	AQ
Bausch Health Companies to Present at Cowen Annual Health Care Conference	Mar. 04	AQ
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors	Feb. 28	BU
Bausch + Lomb: Q4 Earnings Snapshot	Feb. 21	AQ
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance	Feb. 21	BU
Bausch Health Companies Inc. - Salix Announces 2024 Gastrointestinal Health Scholars Program	Feb. 13	AQ
Bausch + Lomb to Present Scientific Data and Analyses on XIPERE at Macula Society Annual Meeting	Feb. 06	AQ
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21	Feb. 05	BU
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22	Feb. 02	AQ
Bausch + Lomb Receives FDA Approval for TENEO Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery	Jan. 09	AQ
Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery	Jan. 08	BU
Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bausch + Lomb Corporation

Equities

BLCO

CA0717051076

Press Releases

Filters